Dendritic Cells Drive Osteosarcomagenesis through Newly Identified Oncogene and Tumor Suppressor

Kevin B Jones1

  • 1Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. Kevin.jones@hci.utah.edu.

Cancer Discovery
|November 3, 2019
PubMed

Insights

The study investigated GRM4 and IL23 in osteosarcoma, finding they influence tumor-infiltrating myeloid cells, not cancer cells. This suggests a new therapeutic target for osteosarcoma treatment.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • The gene GRM4 is suspected to be a tumor suppressor based on Genome-Wide Association Studies (GWAS).
  • Interleukin-23 (IL23) is a cytokine implicated in various cancers and is investigated as a potential oncogene.
  • Osteosarcoma is a primary bone cancer with complex genetic and cellular interactions.

Purpose of the Study:

  • To investigate the roles of GRM4 and IL23 in a mouse model of osteosarcomagenesis.
  • To determine the cellular context in which GRM4 and IL23 exert their functions within the tumor microenvironment.
  • To explore the potential of targeting these genes or their associated pathways in osteosarcoma.

Main Methods:

  • Utilized a mouse model to study osteosarcomagenesis.
  • Analyzed the expression patterns of GRM4 and IL23 within the tumor microenvironment.
  • Investigated the cellular localization and functional impact of GRM4 and IL23 on different cell types within the tumor.

Main Results:

  • Both GRM4 and IL23 were found to be expressed in tumor-infiltrating myeloid-derived antigen-presenting cells.
  • The primary influence of GRM4 and IL23 was observed within these myeloid cells, rather than directly within osteosarcoma cells.
  • This indicates a significant role for the tumor microenvironment, specifically myeloid-derived cells, in osteosarcoma development and progression.

Conclusions:

  • GRM4 and IL23 play crucial roles in the tumor microenvironment, particularly within myeloid-derived antigen-presenting cells.
  • Their influence on osteosarcomagenesis occurs through these immune cells, suggesting a non-cell-autonomous mechanism.
  • Targeting GRM4 or IL23 within the tumor-infiltrating myeloid compartment may represent a novel therapeutic strategy for osteosarcoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K